VSee Health Q3: Cash Falls to $41,666, Going Concern Doubt Reiterated
VSEE sits 17% above its 52-week low of $0.23 on elevated volume (6.1× avg).
Summary
VSee Health's Q3 10-Q shows cash of just $41,666 against a $2,996,674 nine-month operating cash burn, a reiterated going concern warning, and a 35% revenue decline with gross margin collapsing to 21%.
Key Events · Earnings and Guidance · VSEE
-
Cash Nearly Exhausted
Cash was $41,666 at September 30, 2026, versus $5,051,445 at December 31, 2025, after $2,996,674 of operating cash burn from continuing operations over the nine months.
-
Going Concern Doubt Reiterated
Management cites liquidity and historical losses in stating substantial doubt about the ability to continue as a going concern for at least one year; the accumulated deficit reached $87,018,413.
-
Revenue and Margin Deterioration
Q3 revenue fell 35% to $1,496,779 from $2,318,922, and gross margin dropped to 21% from 48% as teleradiology replaced higher-margin Tele-ICU and Virtual Neuro work.
-
New Equity Lines and Convertible Debt
The company established a June 2026 SEPA for up to $10.0M and a Strata SEPA for up to $5.0M, and issued new convertible notes including ADI Funding $271,739, ClearThink $280,000, Vanquish $295,550 and Labrys $336,000.
Analysis · VSEE · Industrial Applications And Services
Cash stood at just $41,666 on September 30, 2026, down from $5,051,445 at year-end 2025, after $2,996,674 of operating cash burn from continuing operations over nine months. Management again flags substantial doubt about the company's ability to continue as a going concern, with the accumulated deficit now at $87,018,413. Q3 revenue fell 35% to $1,496,779 as higher-margin Tele-ICU and Virtual Neuro work gave way to lower-margin teleradiology, dragging gross margin down to 21% from 48%. Survival currently rests on a patchwork of convertible notes and two new equity lines—a June 2026 SEPA of up to $10.0M and a Strata SEPA of up to $5.0M—both dilutive and largely unused so far. With material weaknesses in internal controls still unremediated and a $845,891 lawsuit from Toppan Merrill outstanding, the equity is highly speculative.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VSEE was trading at $0.27 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $199K. The 52-week trading range was $0.23 to $81.60. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.